Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NEOMYCIN Cause Maternal exposure timing unspecified? 58 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Maternal exposure timing unspecified have been filed in association with NEOMYCIN (Antibiotic and Pain Relief). This represents 3.8% of all adverse event reports for NEOMYCIN.

58
Reports of Maternal exposure timing unspecified with NEOMYCIN
3.8%
of all NEOMYCIN reports
54
Deaths
55
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From NEOMYCIN?

Of the 58 reports, 54 (93.1%) resulted in death, 55 (94.8%) required hospitalization, and 58 (100.0%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NEOMYCIN. However, 58 reports have been filed with the FAERS database.

What Other Side Effects Does NEOMYCIN Cause?

Drug hypersensitivity (582) Infusion related reaction (560) Drug ineffective (541) Type 2 diabetes mellitus (517) Swelling (491) Pyrexia (484) Rash (484) Systemic lupus erythematosus (483) Rheumatoid arthritis (478) Off label use (471)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which NEOMYCIN Alternatives Have Lower Maternal exposure timing unspecified Risk?

NEOMYCIN vs NEORAL NEOMYCIN vs NEOSTIGMINE NEOMYCIN vs NEOSTIGMINE METHYLSULFATE NEOMYCIN vs NEPAFENAC NEOMYCIN vs NERATINIB

Related Pages

NEOMYCIN Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified NEOMYCIN Demographics